PITTSBURGH, PA, USA I February 20, 2025 I Myris Therapeuticsâ„¢ emerged from stealth today to announce its strategic focus. Myris, formerly known as ...
New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb 3A6, which may prove to be an important component for Ebola virus ...
23h
Hosted on MSNAstraZeneca Secures China Rights to Anemia Drug, Buying FibroGen Unit in $160M DealBy selling its China business to AstraZeneca, FibroGen can focus on developing a prostate cancer drug and potentially resuming development of roxadustat in another indication.
The "Global TROP2 Antibody Market & Clinical Trials Insight 2029" report has been added to ResearchAndMarkets.com's offering. In what marks a significant leap forward in precision oncology, the TROP2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results